Using an AI-driven algorithm could potentially address the limitations of traditional diagnostic methods by analyzing trends in electronic health records.

Learn about HMGB1's crucial role in liver diseases, its pathways and therapeutic potential that can treat liver diseases.

Liver diseases, both acute and chronic ... plays a role in hepatocellular carcinoma (HCC), influencing tumor proliferation, ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Liver disease is a condition that affects the health ... Primary liver cancer is when cancer initially develops in the liver. Secondary liver cancer is when cancer in another area spreads to ...

Liver cancer is responsible for thousands of deaths each year - but one of the early symptoms is often ignored or mistaken ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint ... yet to share the data behind the ...

Chemomab Therapeutics (CMMB) announced that data from its Phase 2 SPRING trial in patients with primary sclerosing cholangitis was presented at ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Symptoms can include upper abdominal pain, yellow discolouration of the skin and general widespread weakness in the body.

Peking University-led researchers have modified an existing treatment for liver disease that does not cause ... livers from hX4 as humans do, so a secondary location at the nape of the neck ...

Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality ...